Imugene Limited ABN 99 009 179 551 www.imugene.com Suite 12.01, Level 12 4-6 Bligh Street Sydney NSW 2000 AUSTRALIA 9 October 2026 Upcoming Annual General Meeting of Shareholders Dear Shareholder, Imugene Limited ACN 009 179 551 (ASX: IMU or “the Company”), advises that an...
Imugene: Notice of Annual General Meeting/Proxy Form
Filed with ASX · · 52 pages · English
Summary by 6ix AI
Imugene Ltd has issued a Notice of Annual General Meeting and Proxy Form for its upcoming shareholder meeting. The meeting will cover various resolutions including the adoption of the Remuneration Report and the election of directors. Shareholders will have the option to vote virtually and are encouraged to register in advance for the online platform. The notice includes details on voting procedures and shareholder queries related to the meeting.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Story so far
Earlier from Imugene
- Dr John Le Gall appointed Chief Medical Officer
- azer-cel BTKi Cohort Reports new Complete & Partial Response
- Change of Director's Interest Notice - JD
- Application for quotation of securities - IMU
- Cleansing Notice
Later from Imugene
- Notification of cessation of securities - IMU
- Further Responses in azer-cel Phase 1b Trial
- Quarterly Activities/Appendix 4C Cash Flow Report
- Positive amendments to Convertible Notes
- Imugene selected for Poster Presentation at 2026 ASH Meeting
Follow Imugene into a list and get an email when it puts out news.
Follow Imugene